Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating
Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Related Posts
Mizuho Maintains Buy Rating for Intuit: Here’s What You Need To Know
Mizuho has decided to maintain its Buy rating of Intuit (NASDAQ:INTU) and raise its price target from $550.00…
Credit Suisse Maintains Outperform on Dell Technologies, Lowers Price Target to $53
Credit Suisse analyst Shannon Cross maintains Dell Technologies (NYSE:DELL) with a Outperform and lowers the price target from $56 to $53.
Seagen’s Bladder Cancer Trial Data Meets Expectation, Analysts Say
Earlier today, Seagen Inc (NASDAQ:FBI) and Astellas Pharma Inc (OTC:ALPMF) announced topline results from the phase 1b/2 EV-103 trial (KEYNOTE-869) cohort K of Padcev…